Analyst initiations: MNOV, RIG and LII

Posted May 15th 2008 11:09AM by Eric BuscemiEric Buscemi RSS Feed
Filed under: Analyst Reports, Dean Foods (DF), Analyst Initiations

More

MOST NOTEWORTHY: MedicNova, Transocean and Lennox were today's noteworthy initiations:
  • Rodman & Renshaw is positive on MedicNova's (NASDAQ:MNOV) two primary products in development: MN-221, for the treatment of severe asthma and MN-166, an oral treatment for multiple sclerosis. The firm is also positive on MNOV's valuation; shares were initiated with an Outperform rating and $9 target.
  • Transocean (NYSE:RIG) is UBS's Top Pick as they believe it is the primary beneficiary of rising deepwater dayrates. Shares were assumed with a Buy rating and $201 target.
  • Suntrust initiated Lennox (NYSE:LII) with a Neutral rating and cites near-term visibility.
OTHER INITIATIONS:

Tags: analyst, dean foods, DeanFoods, df, hercules, hero, initiation, inthenews, lennox, lii, medicnova, mnov, parker-hannafin, pde, ph, pride, rig, transocean

Symbol Lookup
IndexesChangePrice
DJIA-72.339,986.31
NASDAQ-14.402,136.47
S&P 500-8.431,062.09

Last updated: February 10, 2010: 10:29 AM

Hot Stocks

DailyFinance Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines